nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—PGD—Dacarbazine—hematologic cancer	0.651	0.756	CbGbCtD
Ritodrine—PGD—Methotrexate—hematologic cancer	0.21	0.244	CbGbCtD
Ritodrine—Dienestrol—ESR1—hematologic cancer	0.00288	0.58	CrCbGaD
Ritodrine—Diethylstilbestrol—ABCG2—hematologic cancer	0.00087	0.175	CrCbGaD
Ritodrine—Diethylstilbestrol—ESR1—hematologic cancer	0.000852	0.172	CrCbGaD
Ritodrine—Diethylstilbestrol—ABCB1—hematologic cancer	0.000362	0.0729	CrCbGaD
Ritodrine—ADRB2—Signaling Pathways—HDAC10—hematologic cancer	6.01e-05	0.00045	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CD—hematologic cancer	6e-05	0.000449	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—MAPK3—hematologic cancer	5.97e-05	0.000447	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CREB1—hematologic cancer	5.93e-05	0.000444	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BRAF—hematologic cancer	5.86e-05	0.000439	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PDE4B—hematologic cancer	5.84e-05	0.000437	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CNR2—hematologic cancer	5.84e-05	0.000437	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CCL2—hematologic cancer	5.81e-05	0.000435	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6R—hematologic cancer	5.79e-05	0.000433	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CREBBP—hematologic cancer	5.78e-05	0.000433	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—RAC2—hematologic cancer	5.74e-05	0.00043	CbGpPWpGaD
Ritodrine—PGD—Disease—FGF2—hematologic cancer	5.74e-05	0.00043	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	5.73e-05	0.000429	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CG—hematologic cancer	5.71e-05	0.000428	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3R1—hematologic cancer	5.66e-05	0.000424	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAP2K1—hematologic cancer	5.52e-05	0.000413	CbGpPWpGaD
Ritodrine—PGD—Disease—JAK2—hematologic cancer	5.51e-05	0.000412	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ARHGEF12—hematologic cancer	5.49e-05	0.000411	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—ADCY7—hematologic cancer	5.49e-05	0.000411	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CD—hematologic cancer	5.48e-05	0.00041	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PTHLH—hematologic cancer	5.47e-05	0.000409	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CA—hematologic cancer	5.43e-05	0.000407	CbGpPWpGaD
Ritodrine—PGD—Disease—MDM2—hematologic cancer	5.37e-05	0.000402	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—KRAS—hematologic cancer	5.37e-05	0.000402	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ARHGEF1—hematologic cancer	5.35e-05	0.000401	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PTGER4—hematologic cancer	5.32e-05	0.000399	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CREBBP—hematologic cancer	5.3e-05	0.000397	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGF2—hematologic cancer	5.25e-05	0.000393	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CB—hematologic cancer	5.23e-05	0.000392	CbGpPWpGaD
Ritodrine—PGD—Disease—MTOR—hematologic cancer	5.23e-05	0.000392	CbGpPWpGaD
Ritodrine—PGD—Disease—CD4—hematologic cancer	5.22e-05	0.000391	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3R1—hematologic cancer	5.18e-05	0.000388	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—JAK2—hematologic cancer	5.03e-05	0.000377	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CD—hematologic cancer	5.02e-05	0.000376	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CCL3—hematologic cancer	5.02e-05	0.000376	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTHLH—hematologic cancer	4.96e-05	0.000372	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ALB—hematologic cancer	4.96e-05	0.000371	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CA—hematologic cancer	4.93e-05	0.000369	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MDM2—hematologic cancer	4.91e-05	0.000368	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN1B—hematologic cancer	4.91e-05	0.000367	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTGER4—hematologic cancer	4.83e-05	0.000362	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCL17—hematologic cancer	4.8e-05	0.00036	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AGRN—hematologic cancer	4.8e-05	0.00036	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MTOR—hematologic cancer	4.78e-05	0.000358	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CB—hematologic cancer	4.78e-05	0.000358	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3R1—hematologic cancer	4.74e-05	0.000355	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCR5—hematologic cancer	4.71e-05	0.000353	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCR4—hematologic cancer	4.7e-05	0.000352	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LEF1—hematologic cancer	4.63e-05	0.000347	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—HRAS—hematologic cancer	4.56e-05	0.000342	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNA13—hematologic cancer	4.55e-05	0.000341	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—IL3—hematologic cancer	4.53e-05	0.000339	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN1A—hematologic cancer	4.53e-05	0.000339	CbGpPWpGaD
Ritodrine—PGD—Disease—PTEN—hematologic cancer	4.52e-05	0.000338	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN1B—hematologic cancer	4.48e-05	0.000336	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TIAM1—hematologic cancer	4.48e-05	0.000335	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AKT1—hematologic cancer	4.43e-05	0.000332	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CASP3—hematologic cancer	4.39e-05	0.000329	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL2—hematologic cancer	4.39e-05	0.000329	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—RASGRP1—hematologic cancer	4.38e-05	0.000328	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CB—hematologic cancer	4.38e-05	0.000328	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL6—hematologic cancer	4.37e-05	0.000327	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—CCL2—hematologic cancer	4.36e-05	0.000326	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JAK3—hematologic cancer	4.34e-05	0.000325	CbGpPWpGaD
Ritodrine—PGD—Disease—EP300—hematologic cancer	4.31e-05	0.000323	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CCND1—hematologic cancer	4.28e-05	0.00032	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCR4—hematologic cancer	4.27e-05	0.00032	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—JUN—hematologic cancer	4.27e-05	0.00032	CbGpPWpGaD
Ritodrine—PGD—Disease—SRC—hematologic cancer	4.19e-05	0.000314	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCR7—hematologic cancer	4.16e-05	0.000312	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCL13—hematologic cancer	4.16e-05	0.000312	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN1A—hematologic cancer	4.14e-05	0.00031	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTEN—hematologic cancer	4.13e-05	0.000309	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL3—hematologic cancer	4.12e-05	0.000308	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NCOR2—hematologic cancer	4.11e-05	0.000308	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL3RA—hematologic cancer	4.06e-05	0.000304	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CRKL—hematologic cancer	4.06e-05	0.000304	CbGpPWpGaD
Ritodrine—PGD—Disease—STAT3—hematologic cancer	4.04e-05	0.000303	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAPK8—hematologic cancer	4.04e-05	0.000302	CbGpPWpGaD
Ritodrine—PGD—Disease—NRAS—hematologic cancer	4.03e-05	0.000302	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AKT1—hematologic cancer	4.03e-05	0.000302	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—RASGRP1—hematologic cancer	3.98e-05	0.000298	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GRB2—hematologic cancer	3.94e-05	0.000295	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EP300—hematologic cancer	3.94e-05	0.000295	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RGS2—hematologic cancer	3.91e-05	0.000293	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CMA1—hematologic cancer	3.87e-05	0.00029	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TRH—hematologic cancer	3.87e-05	0.00029	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TRIO—hematologic cancer	3.87e-05	0.00029	CbGpPWpGaD
Ritodrine—PGD—Disease—MAPK3—hematologic cancer	3.86e-05	0.000289	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SRC—hematologic cancer	3.83e-05	0.000287	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AGO2—hematologic cancer	3.79e-05	0.000284	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SPHK1—hematologic cancer	3.79e-05	0.000284	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTEN—hematologic cancer	3.78e-05	0.000283	CbGpPWpGaD
Ritodrine—PGD—Disease—MYC—hematologic cancer	3.75e-05	0.000281	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HDAC9—hematologic cancer	3.75e-05	0.000281	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LPAR1—hematologic cancer	3.75e-05	0.000281	CbGpPWpGaD
Ritodrine—PGD—Disease—TGFB1—hematologic cancer	3.75e-05	0.00028	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VEGFA—hematologic cancer	3.73e-05	0.000279	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—H3F3B—hematologic cancer	3.71e-05	0.000278	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—STAT3—hematologic cancer	3.69e-05	0.000276	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NRAS—hematologic cancer	3.68e-05	0.000276	CbGpPWpGaD
Ritodrine—PGD—Metabolism—EP300—hematologic cancer	3.61e-05	0.00027	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GRB2—hematologic cancer	3.58e-05	0.000268	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MAPK3—hematologic cancer	3.53e-05	0.000264	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CSF2—hematologic cancer	3.52e-05	0.000264	CbGpPWpGaD
Ritodrine—PGD—Disease—KRAS—hematologic cancer	3.47e-05	0.00026	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDE4B—hematologic cancer	3.45e-05	0.000258	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CNR2—hematologic cancer	3.45e-05	0.000258	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MYC—hematologic cancer	3.43e-05	0.000257	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TGFB1—hematologic cancer	3.42e-05	0.000256	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF19—hematologic cancer	3.42e-05	0.000256	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—JAK1—hematologic cancer	3.4e-05	0.000255	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PRKCG—hematologic cancer	3.4e-05	0.000255	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RAC2—hematologic cancer	3.39e-05	0.000254	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DKK1—hematologic cancer	3.37e-05	0.000252	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT5B—hematologic cancer	3.34e-05	0.00025	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ADCY7—hematologic cancer	3.24e-05	0.000243	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CSF2—hematologic cancer	3.2e-05	0.00024	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CA—hematologic cancer	3.19e-05	0.000239	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—IL2RA—hematologic cancer	3.18e-05	0.000238	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KRAS—hematologic cancer	3.17e-05	0.000237	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—XIAP—hematologic cancer	3.15e-05	0.000236	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PRKCG—hematologic cancer	3.09e-05	0.000231	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—JAK1—hematologic cancer	3.09e-05	0.000231	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SH2B3—hematologic cancer	3.07e-05	0.00023	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SMARCA4—hematologic cancer	3.07e-05	0.00023	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GZMB—hematologic cancer	3.06e-05	0.000229	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CTNNA1—hematologic cancer	2.98e-05	0.000223	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EIF4EBP1—hematologic cancer	2.97e-05	0.000222	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HSPB1—hematologic cancer	2.97e-05	0.000222	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCL3—hematologic cancer	2.97e-05	0.000222	CbGpPWpGaD
Ritodrine—PGD—Disease—HRAS—hematologic cancer	2.95e-05	0.000221	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTHLH—hematologic cancer	2.93e-05	0.00022	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SDC1—hematologic cancer	2.93e-05	0.00022	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CA—hematologic cancer	2.91e-05	0.000218	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL2RA—hematologic cancer	2.88e-05	0.000216	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTGER4—hematologic cancer	2.86e-05	0.000214	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LCK—hematologic cancer	2.84e-05	0.000213	CbGpPWpGaD
Ritodrine—PGD—Disease—IL6—hematologic cancer	2.82e-05	0.000211	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TP53—hematologic cancer	2.82e-05	0.000211	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—H3F3A—hematologic cancer	2.78e-05	0.000208	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKCZ—hematologic cancer	2.71e-05	0.000203	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HRAS—hematologic cancer	2.69e-05	0.000202	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CA—hematologic cancer	2.67e-05	0.0002	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	2.65e-05	0.000198	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PARP1—hematologic cancer	2.61e-05	0.000196	CbGpPWpGaD
Ritodrine—PGD—Disease—AKT1—hematologic cancer	2.6e-05	0.000195	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL6—hematologic cancer	2.58e-05	0.000193	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	2.57e-05	0.000193	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	2.52e-05	0.000189	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	2.52e-05	0.000189	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CBL—hematologic cancer	2.46e-05	0.000184	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL3—hematologic cancer	2.43e-05	0.000182	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	2.4e-05	0.00018	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	2.39e-05	0.000179	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKT1—hematologic cancer	2.38e-05	0.000178	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	2.36e-05	0.000177	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	2.35e-05	0.000176	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	2.34e-05	0.000176	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SYK—hematologic cancer	2.34e-05	0.000176	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	2.33e-05	0.000174	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	2.29e-05	0.000171	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT1—hematologic cancer	2.26e-05	0.000169	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	2.24e-05	0.000168	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	2.23e-05	0.000167	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.2e-05	0.000164	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKT1—hematologic cancer	2.18e-05	0.000163	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	2.13e-05	0.00016	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	2.13e-05	0.000159	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GRB2—hematologic cancer	2.12e-05	0.000158	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	2.11e-05	0.000158	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	2.11e-05	0.000158	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KITLG—hematologic cancer	2.08e-05	0.000156	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	2.03e-05	0.000152	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	2.03e-05	0.000152	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	2.02e-05	0.000151	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	1.99e-05	0.000149	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CD86—hematologic cancer	1.95e-05	0.000146	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	1.94e-05	0.000145	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HES1—hematologic cancer	1.92e-05	0.000144	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	1.91e-05	0.000143	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CSF2—hematologic cancer	1.89e-05	0.000142	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF1—hematologic cancer	1.89e-05	0.000142	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	1.86e-05	0.000139	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	1.86e-05	0.000139	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	1.86e-05	0.000139	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	1.84e-05	0.000138	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	1.83e-05	0.000137	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JAK1—hematologic cancer	1.82e-05	0.000137	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	1.82e-05	0.000137	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	1.7e-05	0.000128	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL2—hematologic cancer	1.69e-05	0.000127	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TERT—hematologic cancer	1.68e-05	0.000126	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	1.64e-05	0.000123	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TSC2—hematologic cancer	1.61e-05	0.00012	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	1.55e-05	0.000116	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	1.53e-05	0.000115	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ESR1—hematologic cancer	1.5e-05	0.000112	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FN1—hematologic cancer	1.48e-05	0.000111	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	1.47e-05	0.00011	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BAD—hematologic cancer	1.47e-05	0.00011	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	1.45e-05	0.000109	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CD80—hematologic cancer	1.42e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KIT—hematologic cancer	1.42e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	1.42e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	1.42e-05	0.000106	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	1.39e-05	0.000104	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	1.36e-05	0.000102	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CREB1—hematologic cancer	1.35e-05	0.000101	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BRAF—hematologic cancer	1.33e-05	9.99e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCL2—hematologic cancer	1.32e-05	9.9e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6R—hematologic cancer	1.32e-05	9.87e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	1.32e-05	9.85e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	1.26e-05	9.4e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	1.25e-05	9.34e-05	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.24e-05	9.25e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	1.22e-05	9.15e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF2—hematologic cancer	1.19e-05	8.95e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	1.18e-05	8.82e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JAK2—hematologic cancer	1.15e-05	8.57e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	1.12e-05	8.4e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MDM2—hematologic cancer	1.12e-05	8.37e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	1.09e-05	8.14e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MTOR—hematologic cancer	1.09e-05	8.14e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	1.04e-05	7.77e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	1.02e-05	7.64e-05	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	1.01e-05	7.56e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CASP3—hematologic cancer	1e-05	7.49e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL2—hematologic cancer	9.99e-06	7.48e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL6—hematologic cancer	9.94e-06	7.44e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCND1—hematologic cancer	9.74e-06	7.29e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JUN—hematologic cancer	9.72e-06	7.28e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	9.42e-06	7.05e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTEN—hematologic cancer	9.4e-06	7.04e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	9.19e-06	6.88e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	9.17e-06	6.86e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EP300—hematologic cancer	8.96e-06	6.71e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SRC—hematologic cancer	8.71e-06	6.53e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	8.49e-06	6.36e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT3—hematologic cancer	8.4e-06	6.29e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NRAS—hematologic cancer	8.38e-06	6.28e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	8.03e-06	6.01e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MYC—hematologic cancer	7.81e-06	5.85e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	7.79e-06	5.83e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KRAS—hematologic cancer	7.22e-06	5.4e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	6.63e-06	4.96e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TP53—hematologic cancer	6.41e-06	4.8e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HRAS—hematologic cancer	6.13e-06	4.59e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL6—hematologic cancer	5.87e-06	4.4e-05	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT1—hematologic cancer	5.42e-06	4.06e-05	CbGpPWpGaD
